Marianne Lind
Molecular Biology · 2022
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 23 citations into it
- Biomaterials — 6 citations into it
- Biomedical Engineering — 6 citations into it
Whom Marianne Lind trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Marianne Lind's perspective
Ordered by how strongly the researchers Marianne Lind trusts endorse each paper. Same corpus, a different order for every researcher.
- A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates. (Molecular Therapy)
- Pharmacokinetics and biodistribution of nanoparticles. (Molecular Pharmaceutics)
- Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling (Nature Biotechnology)
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine (New England Journal of Medicine)
- Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines (Molecular Therapy: Nucleic Acids)
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms. (Molecular Therapy)
- Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs. (Nano letters (Print))
- Mechanism of hard nanomaterial clearance by the liver (Nature Materials)
- Pharmacokinetics of Pegylated Liposomal Doxorubicin (Clinical Pharmacokinetics)
- Selective ORgan Targeting (SORT) nanoparticles for tissue specific mRNA delivery and CRISPR/Cas gene editing (Nature Nanotechnology)
Their papers
- The role of lipid components in lipid nanoparticles for vaccines and gene therapy (2022) — 966 citations